The MarketWatch News Department was not involved in the creation of this content. The Federal Trade Commission is sending more than $10.9 million to consumers harmed by a credit repair operation known ...
Add Yahoo as a preferred source to see more of our stories on Google. Donald Trump is known for his hasty (and frequent) posts on social media. But in recent months, select posts have concluded with ...
Brianna "Chickenfry" LaPaglia is slamming the use of Ozempic for weight loss. The reality TV star and Barstool Sports personality, 26, got candid about the growing use of GLP-1 weight loss medications ...
Although one GLP-1 study made national headlines about the drug class’ potential use in addiction treatment, other research indicates GLP-1s could increase the risk of bone injuries and are less ...
ATLANTA — The Federal Trade Commission on Wednesday announced it is sending more than $47 million in checks to renters who were deceived by Invitation Homes, one of the largest landlords in the ...
AUSTIN, Texas, March 10, 2026 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (FTCI), a leading provider of solar tracker systems, software, and engineering services, announced today that it has signed a ...
Tracker manufacturer FTC Solar has signed a five-year, 1-GW supply agreement with U.S. developer Strata Clean Energy. “As we conclude our first 500 MW of 2P projects with Strata, we’re incredibly ...
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. New research suggests prolonged GLP-1 use may be linked ...
New data suggest a link between using GLP-1 receptor agonists (GLP-1 RAs) and a significantly higher risk for tendon ruptures, primarily tears involving the rotator cuff, Achilles, and pectoralis ...
Target-trial emulation in VA EHRs constructed eight parallel new-user trials comparing GLP-1 RA initiators with SGLT-2 inhibitor initiators under two protocols: incident SUDs and SUD-related adverse ...
What began as an unexpected observation and “side effect” of some medications converged with decades of addiction neuroscience: GLP-1 receptor agonist medications like Ozempic apparently reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results